Skip to main content
Lisa Beck, MD, Dermatology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

LisaAnnBeckMD

Dermatology Rochester, NY

Professor, Dermatology, Medicine and Pathology, University of Rochester School of Medicine & Dentistry

Dr. Beck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Beck's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityAllergy & Immunology, 1992 - 1994
  • Duke University Hospital
    Duke University HospitalResidency, Dermatology, 1987 - 1990
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 1985 - 1987
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 1985

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2025
  • MD State Medical License
    MD State Medical License 1990 - 2006
  • NC State Medical License
    NC State Medical License 1987 - 1992
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Image Gallery: Hairy‐Cell Leukaemia Presenting with Sweet Syndrome  
    G Scott, L A Beck, The British Journal of Dermatology

Lectures

  • Atopic Dermatitis 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Press Mentions

  • Every-Other-Week Dose of Dupilumab Safe, Effective over Long Term
    Every-Other-Week Dose of Dupilumab Safe, Effective over Long TermMay 12th, 2022
  • DermTech Announces New Scientific Advisory Board Members
    DermTech Announces New Scientific Advisory Board MembersFebruary 8th, 2021
  • Research Finds Needleless Flu Vaccine Patch to Be Effective
    Research Finds Needleless Flu Vaccine Patch to Be EffectiveSeptember 19th, 2019
  • Join now to see all

Grant Support

  • Mechanisms Of Chemokine-Induced Inflammation In HumansNational Institute Of Allergy And Infectious Diseases2001–2005
  • Steroid Mechanisms In Cutaneous Allergic InflammationNational Institute Of Allergy And Infectious Diseases1994–1998

Professional Memberships

Hospital Affiliations